News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PD-Rx Pharmaceuticals, Inc. (PDRX.PK) Acquires Wilson Medical's EMR


6/24/2011 6:13:32 AM

OKLAHOMA CITY, June 23, 2011 /PRNewswire/ -- PD-Rx Pharmaceuticals, Inc., a publicly held corporation, (Symbol: PDRX.PK) today announced the purchase of the Washington EMR, an electronic medical record, from Wilson Medical Software, LLC.

Washington EMR is the premier quality, low-cost tool for physicians to maintain patient charts electronically. The intuitive interface allows the physician and assistants to rapidly record visit notes and generate prescriptions. Washington EMR computerizes patient records through the use of standard templates that can be edited on the fly.

PD-Rx also welcomes Mr. Eric Wilson to the software development team. As President of Wilson Medical Software, Mr. Wilson developed the Electronic Medical Record software program while working closely with physicians in California. Mr. Wilson has decades of software experience in various technologies including experience in the Java/Unix and Microsoft environments, developing both front end and back end software for medical practices.

ABOUT THE COMPANY:

PD-Rx offers pharmaceutical and management strategies to the healthcare industry. Our management strategies focus on new products, solid business partners, and the specialized segment of the pharmaceutical industry. As a licensed FDA manufacturer and packager, PD-Rx offers a full spectrum of medications and specialized services. Our goal is to develop a matrix of cost containment tools and products that we can merge into any healthcare network to enhance patient care and improve managed care organizations bottom line. We provide proprietary software, products and prepackaged medications that are viewed by patient, insurance payers and healthcare providers as a progressive and responsive practice.

This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks and uncertainties or other factors, which may cause actual results, performance or achievements expressed or implied by such forward-looking statements to vary from those forecast or implied in this release. Factors that might cause such a difference include, without limitation, decline in demand for the company's products or services, and the effect of general economic conditions and factors affecting the industry.

Jack L. McCall, EVP & COO
Ph. 405-942-3040 / jlm@pdrx.com

SOURCE PD-Rx Pharmaceuticals, Inc.


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES